Lantheus Holdings, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
Lantheus Holdings, Inc. (LNTH) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value of $0 as of 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue · last filed 2024-02-22
- 2023-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
- 2023-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
- 2023-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
- 2023-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-22 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-22 |
| 2022-09-30 | $8.20M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $7.70M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $8.90M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $9.30M 10-K · filed 2024-02-22 |
| 2021-09-30 | $13.80M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $13.40M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $12.20M 10-Q · filed 2022-04-29 |
| 2020-12-31 | $11.30M 10-K · filed 2023-02-23 |
| 2020-09-30 | $10.20M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $10.10M 10-Q · filed 2021-07-28 |
| 2020-03-31 | $0.00 10-Q · filed 2020-07-31 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |